Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Prestige Consumer Healthcare (PBH) Other Operating Expenses (2016 - 2025)

Prestige Consumer Healthcare has reported Other Operating Expenses over the past 14 years, most recently at $42.8 million for Q4 2025.

  • Quarterly results put Other Operating Expenses at $42.8 million for Q4 2025, up 4.3% from a year ago — trailing twelve months through Dec 2025 was $173.3 million (up 2.41% YoY), and the annual figure for FY2025 was $179.8 million, up 7.22%.
  • Other Operating Expenses for Q4 2025 was $42.8 million at Prestige Consumer Healthcare, up from $41.4 million in the prior quarter.
  • Over the last five years, Other Operating Expenses for PBH hit a ceiling of $405.1 million in Q1 2023 and a floor of $34.8 million in Q4 2022.
  • Median Other Operating Expenses over the past 5 years was $43.0 million (2022), compared with a mean of $60.9 million.
  • Biggest five-year swings in Other Operating Expenses: skyrocketed 844.46% in 2023 and later tumbled 89.89% in 2024.
  • Prestige Consumer Healthcare's Other Operating Expenses stood at $44.7 million in 2021, then fell by 22.08% to $34.8 million in 2022, then increased by 23.79% to $43.1 million in 2023, then dropped by 4.87% to $41.0 million in 2024, then grew by 4.3% to $42.8 million in 2025.
  • The last three reported values for Other Operating Expenses were $42.8 million (Q4 2025), $41.4 million (Q3 2025), and $37.6 million (Q2 2025) per Business Quant data.